Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPEPL1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | B4GALT4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | PTGDS | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
mRNA | DNAJC4 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | CDC123 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | GRAMD2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | F11R | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | CASP8AP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | MCM2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | SPSB1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |